In addition, unique BCR/ABL hybrid gene-containing EVs derived from human chronic myelogenous leukemia K562 cells were found to be transportable to HEK293 cells or neutrophils, resulting in the expression of the BCR/ABL hybrid gene mRNA and protein in the recipient cells [86]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.